Price Move History
- Daily moves over 5%
- 96 252 sessions, May 24, 2022 to May 24, 2023
- Largest daily move
- -60.7% close of May 15, 2023
- 1-year change
- -98% closing prices, May 24, 2022 to May 24, 2023
- 1-month change
- -83.8% closing prices, April 24, 2023 to May 24, 2023
Company Description
Athenex (Nasdaq: ATNX) is classified in the drug manufacturers—specialty & generic industry within the Healthcare sector.
ATNX declined 98.0% in the 12 months to May 24, 2023. The last closing price was $0.2031.
This page collects what Stock Titan holds for ATNX, including price data and latest news.
Stock Performance
Athenex (ATNX) closed at $0.2031 on May 24, 2023. In the 12 months to May 24, 2023, the price lost 98.0%.
ATNX Metrics & Rankings
Price returns through May 24, 2023. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Athenex has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, stock split, conferences. View all ATNX news →
SEC Filings
ATNX Company Profile & Sector Positioning
Athenex (ATNX) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector.
Investors comparing ATNX often look at related companies in the same sector, including Takeda Pharmaceutical Company Limited (TAK), Teva Pharmaceutical Industries Limited (TEVA), Haleon plc (HLN), Zoetis Inc. (ZTS), and United Therapeutics Corp (UTHR). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ATNX's relative position within its industry.